Arcus Biosciences

A picture is worth a thousand words; at the #ASCO25 Annual Meeting, view customized digital portraits that reflect the narrative of a people’s lives that have been touched by #cancer. As some of the brightest minds in oncology gather, we’re reminded that the heart of our work at Arcus is – and always will be – the patients we serve. Visit our booth #36103 and learn more about #PortrAItsofCancer: https://bit.ly/4eCl3BV Colorectal Cancer Alliance | Debbie's Dream Foundation: Curing Stomach Cancer | Kidney Cancer Association | LUNGevity Foundation | Pancreatic Cancer Action Network | Worth the Wait Charity

Hello #ASCO25! Stop by our booth #36103 to learn more about our ongoing Phase 3 studies being developed to tackle some of the most common cancers with new investigational combination treatments including lung, upper GI, pancreatic and kidney cancer. Not at ASCO this year? Check out our clinical pipeline here: https://bit.ly/4kt2Ryv

At Arcus, our investigational therapies are a story of scientific precision, persistence and thoughtful engineering. Our small-molecule team took on the challenge of designing a next-generation HIF-2a inhibitor that could address known limitations and support future combination strategies in #KidneyCancer. With #ASCO25 right around the corner, learn about the science and strategy behind its development: https://bit.ly/3D3lkkE

In the months that followed her father’s diagnosis with #PancreaticCancer, Tori Larrick’s family camped, road-tripped, and soaked in every moment together. After her father’s passing, Tori not only found healing in being outdoors, but also in joining a grief group for teens leading to her career in patient services. Today, Tori supports patients and families through her work at the Pancreatic Cancer Action Network, helping others navigate the same diagnosis that changed her life. ➡️ Follow us for more inspiring stories like Tori’s and meet others transforming pain into purpose. 🔗 See her full story and explore the full #PortrAltsofCancer gallery: https://bit.ly/3GN3yUr

We’re reporting our first-quarter financial results and an update on our clinical-stage pipeline. https://bit.ly/3SnOAqp

Ten years ago, we set out to challenge the limits of what cancer treatment could achieve. Today, we celebrate a decade of progress, with this milestone reflecting our commitment to innovation, collaboration, and the pursuit of cures for cancer. A huge thank you to Team Arcus, as well as our partners, patients, investigators, and everyone who has taken part in our mission to bring life-changing new therapies to people with cancer. #10Years

Earlier this week, we were at the #AACR25 Annual Meeting presenting our latest preclinical #cancer research. Access our presentations here: https://bit.ly/4h5AvrF

First combination data for casdatifan, our HIF-2a inhibitor for the treatment of metastatic #KidneyCancer, will be presented in an oral session at the #ASCO25 Annual Meeting. Read more about this news: https://bit.ly/42VUcya

𝐅𝐫𝐨𝐦 𝐭𝐡𝐞 𝐁𝐚𝐲 𝐀𝐫𝐞𝐚: On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73. He describes the market potential of the company's HIF-2⍺, a target that has already been de-risked by a large pharma, why he believes being Fc silent will allow Arcus to succeed in TIGIT where others have failed, and a CD73 program that is enrolling very quickly in pancreatic cancer. Full video: https://lnkd.in/gcSaYJQE BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills

Behind every doctor is a story – a reason that led them to dedicating their career to the health and wellness of others. Whether it was a loved one’s illness, a fascination with science, or a desire to help others, that “why” drives them every day. In honor of #NationalDoctorsDay, our chief medical officer, Richard Markus, discusses his ongoing commitment to patients and the medical field. We at Arcus #ThankYouDoctors for all that you do!